Cargando…

Obesity and the microbiome in atopic dermatitis: Therapeutic implications for PPAR-γ agonists

Atopic dermatitis (AD) is an inflammatory skin disease characterized by epidermal barrier disruption, Th2 immune responses to skin allergens and microbial dysbiosis within affected lesions. Studies within the past decade have revealed genetic and environmental factors contributing to AD in children....

Descripción completa

Detalles Bibliográficos
Autor principal:	McAleer, Jeremy P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Allergy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083318/ https://www.ncbi.nlm.nih.gov/pubmed/37051264 http://dx.doi.org/10.3389/falgy.2023.1167800

Ejemplares similares

Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
por: Dubini, Marco, et al.
Publicado: (2023)

Survey of topical exposure concerns for patients and caregivers dealing with atopic dermatitis
por: Ratley, Grace, et al.
Publicado: (2023)

Proteomics Profiling to Distinguish DOCK8 Deficiency From Atopic Dermatitis
por: Jacob, Minnie, et al.
Publicado: (2021)

Navigating patients with atopic dermatitis or chronic spontaneous urticaria during the COVID-19 pandemic
por: Haddad, Isabelle, et al.
Publicado: (2022)

Peripheral Blood Gene Expression Profile of Infants with Atopic Dermatitis
por: Nousbeck, Janna, et al.
Publicado: (2022)

Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients
por: Roekevisch, E., et al.
Publicado: (2020)

Validation of the Patient‐Oriented SCORing for Atopic Dermatitis tool for black skin
por: Faye, O., et al.
Publicado: (2019)

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatitis from the BREEZE‐AD7 Phase 3 randomized trial
por: Wollenberg, A., et al.
Publicado: (2021)

Both children and adult patients with difficult‐to‐treat atopic dermatitis have high prevalences of concomitant allergic contact dermatitis and are frequently polysensitized
por: Boonstra, M., et al.
Publicado: (2018)

Effective Primary Prevention of Atopic Dermatitis in High-Risk Neonates via Moisturizer Application: Protocol for a Randomized, Blinded, Parallel, Three-Group, Phase II Trial (PAF Study)
por: Inuzuka, Yusuke, et al.
Publicado: (2022)

Changes in nano-mechanical properties of human epidermal cornified cells in children with atopic dermatitis
por: Haftek, Marek, et al.
Publicado: (2020)

Topical corticosteroids normalize both skin and systemic inflammatory markers in infant atopic dermatitis
por: McAleer, M. A., et al.
Publicado: (2021)

The patient‐reported disease burden in adults with atopic dermatitis: a cross‐sectional study in Europe and Canada
por: de Bruin‐Weller, M., et al.
Publicado: (2020)

Itch in Allergic Contact Dermatitis
por: Lambert, Julien
Publicado: (2021)

Microbiome in atopic dermatitis
por: Wollina, Uwe
Publicado: (2017)

The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians
por: van der Kraaij, G.E., et al.
Publicado: (2020)

Patient‐reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate‐to‐severe atopic dermatitis
por: Thyssen, J.P., et al.
Publicado: (2021)

Impact of oral abrocitinib on signs, symptoms and quality of life among adolescents with moderate‐to‐severe atopic dermatitis: an analysis of patient‐reported outcomes
por: Cork, M.J., et al.
Publicado: (2021)

PPARγ Agonists: Potential as Therapeutics for Neovascular Retinopathies
por: Pershadsingh, Harrihar A., et al.
Publicado: (2008)

Stepwise approach of development of dermo‐cosmetic products in healthy and atopic dermatitis paediatric population: safety evaluation, clinical development and postmarket surveillance
por: Ribet, V., et al.
Publicado: (2019)

339 Sensitization to Contactants in Patients with Atopic Dermatitis
por: Matsumoto, Fausto, et al.
Publicado: (2012)

Iron-Deficiency in Atopic Diseases: Innate Immune Priming by Allergens and Siderophores
por: Roth-Walter, Franziska
Publicado: (2022)

The microbiome in patients with atopic dermatitis
por: Paller, Amy S., et al.
Publicado: (2018)

Skin Microbiome in Atopic Dermatitis
por: EDSLEV, Sofie M., et al.
Publicado: (2020)

Early inhalant allergen sensitization at component level: an analysis in atopic Dutch children
por: Landzaat, Lonneke J., et al.
Publicado: (2023)

Adhesion of Staphylococcus aureus to Corneocytes from Atopic Dermatitis Patients Is Controlled by Natural Moisturizing Factor Levels
por: Feuillie, Cécile, et al.
Publicado: (2018)

Non-atopic Neonatal Thymic Innate Lymphoid Cell Subsets (ILC1, ILC2, and ILC3) Identification and the Modulatory Effect of IgG From Dermatophagoides Pteronyssinus (Derp)-Atopic Individuals
por: de Sousa, Thamires Rodrigues, et al.
Publicado: (2021)

Therapeutic potential of PPARγ natural agonists in liver diseases
por: Wu, Liwei, et al.
Publicado: (2020)

344 FcRγ-mediated Immune Responses Modulate the Exacerbation of Clinical Symptoms in Atopic Dermatitis of NC/TND Mice
por: Oida, Kumiko, et al.
Publicado: (2012)

341 Quality of Life in Pediatric Patients with Atopic Dermatitis
por: Campos, Xiomara Lopez
Publicado: (2012)

49 Metallic Soap Aggravates Skin Conditions in Patients With Atopic Dermatitis and a Mouse Model for Human Atopic Dermatitis, NC/TND Mice
por: Tanaka, Akane, et al.
Publicado: (2012)

Filaggrin breakdown products determine corneocyte conformation in patients with atopic dermatitis
por: Riethmuller, Christoph, et al.
Publicado: (2015)

The role of the respiratory microbiome in asthma
por: Campbell, Christina D., et al.
Publicado: (2023)

Resveratrol ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis-like lesions through effects on the epithelium
por: Caglayan Sozmen, Sule, et al.
Publicado: (2016)

A phase 2, open‐label study of single‐dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy
por: Paller, A.S., et al.
Publicado: (2020)

Therapeutic Implications of PPARγ in Human Osteosarcoma
por: Wagner, Eric R., et al.
Publicado: (2010)

Therapeutic Implications of PPARγ in Cardiovascular Diseases
por: Hasegawa, Hiroshi, et al.
Publicado: (2010)

The Pathogenic and Therapeutic Implications of Ceramide Abnormalities in Atopic Dermatitis
por: Fujii, Masanori
Publicado: (2021)

Role of the skin microbiome in atopic dermatitis
por: Salava, Alexander, et al.
Publicado: (2014)

Systemic and stratum corneum biomarkers of severity in infant atopic dermatitis include markers of innate and T helper cell‐related immunity and angiogenesis
por: McAleer, M.A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1npibuhqrfdsg0l3a8j6bbo1ip